Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia & Upjohn switch-oriented OTC business has annual sales of about $400 mil..

This article was originally published in The Tan Sheet

Executive Summary

PHARMACIA & UPJOHN's SWITCH-ORIENTED OTC BUSINESSES will have combined annual sales of about $400 mil. worldwide. OTC sales are expected to comprise about 6% of a new entity, Pharmacia & Upjohn, that will be formed under a combination agreement announced by the two companies on Aug. 20. Pharmacia and Upjohn had approximately $6.8 bil. in combined revenues in 1994. Prescription pharmaceuticals represent about 78% of the merged entity's total sales based on 1994 figures.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084240

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel